Squamous-cell carcinoma of the skin

A Wysong - New England Journal of Medicine, 2023 - Mass Medical Soc
Squamous-Cell Carcinoma of the Skin | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Advances in cutaneous squamous cell carcinoma management

C Burns, S Kubicki, QB Nguyen, N Aboul-Fettouh… - Cancers, 2022 - mdpi.com
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is an increasingly prevalent
and morbid cancer worldwide. Management of this cancer has changed significantly in the …

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

P Bailey, RA Ridgway, P Cammareri… - Nature …, 2023 - nature.com
The molecular basis of disease progression from UV-induced precancerous actinic keratosis
(AK) to malignant invasive cutaneous squamous cell carcinoma (cSCC) and potentially …

[HTML][HTML] European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European Journal of …, 2023 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
white populations, accounting for 20% of all cutaneous malignancies. Overall, cSCC mostly …

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

B Rentroia-Pacheco, S Tokez, EM Bramer… - …, 2023 - thelancet.com
Background Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer,
affecting more than 2 million people worldwide yearly and metastasising in 2–5% of …

Distinguishing keratoacanthoma from well-differentiated cutaneous squamous cell carcinoma using single-cell spatial pathology

J Veenstra, D Ozog, I Loveless, I Adrianto… - Journal of Investigative …, 2023 - Elsevier
Keratoacanthoma (KA) is a common keratinocyte neoplasm that is regularly classified as a
type of cutaneous squamous cell carcinoma (cSCC) despite demonstrating benign behavior …

Squamous cell carcinoma: an update in staging, management, and postoperative surveillance strategies

AK Guzman, CD Schmults, ES Ruiz - Dermatologic Clinics, 2023 - derm.theclinics.com
Invasive cutaneous squamous cell carcinoma (cSCC) represents the second-most prevalent
cutaneous malignancy, with over 1 million estimated new cases diagnosed annually in the …

Follow-up of patients with keratinocyte carcinoma: a systematic review of clinical practice guidelines

S Mirali, E Tang, AM Drucker, I Turchin… - JAMA …, 2023 - jamanetwork.com
Importance Patients treated for cutaneous squamous cell carcinoma (SCC) and basal cell
carcinoma (BCC), collectively called keratinocyte carcinoma (KC), are at risk for recurrence …

Rates of second tumor, metastasis, and death from cutaneous squamous cell carcinoma in patients with and without transplant-associated immunosuppression

P Gjersvik, RS Falk, I Roscher, SMH Rizvi… - JAMA …, 2023 - jamanetwork.com
Importance Cutaneous squamous cell carcinoma (cSCC) may occur with multiple primary
tumors, metastasize, and cause death both in immunocompetent and immunosuppressed …

Recommendations for risk stratification of periocular squamous cell carcinoma

JY Tong, SC Huilgol, C James, D Selva - Survey of Ophthalmology, 2023 - Elsevier
Periocular squamous cell carcinoma is a common cutaneous malignancy with generally
favorable outcomes; however, the periocular region is intrinsically a high-risk location, and …